Zeer Oviva / intent / oviva

Oviva

251-1K employees·Zürich, Zurich, Switzerland·oviva.com

Observed, not inferred · updated weekly

Buying intent

26 tracked signals | Top 15 topics are below | Marketing and Engineering are carrying most of it.

25signals · 30 days
16topics tracked
26.67%attributed to a team

Attention by team

LinkedIn activity, by team

Where Oviva's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Mental Health
Weight Management
Healthcare AI
Health Care
Digital Health
Marketing
Marketing to Artificial Intelligence: no signal
Medium33% of team Marketing to Mental Health: Medium, 33% of this team's signals
Medium33% of team Marketing to Weight Management: Medium, 33% of this team's signals
Marketing to Healthcare AI: no signal
Medium33% of team Marketing to Health Care: Medium, 33% of this team's signals
Marketing to Digital Health: no signal
Engineering
Medium100% of team Engineering to Artificial Intelligence: Medium, 100% of this team's signals
Engineering to Mental Health: no signal
Engineering to Weight Management: no signal
Engineering to Healthcare AI: no signal
Engineering to Health Care: no signal
Engineering to Digital Health: no signal
Others
High27% of team Others to Artificial Intelligence: High, 27% of this team's signals
High18% of team Others to Mental Health: High, 18% of this team's signals
Medium9% of team Others to Weight Management: Medium, 9% of this team's signals
High18% of team Others to Healthcare AI: High, 18% of this team's signals
Medium9% of team Others to Health Care: Medium, 9% of this team's signals
High18% of team Others to Digital Health: High, 18% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
96%
last
10d ago
Mental Health
LinkedIn
High volume
96%
last
24d ago
Weight Management
LinkedIn
Medium volume
96%
last
24d ago
Healthcare AI
LinkedIn
Medium volume
92%
last
16d ago
Health Care
LinkedIn
Medium volume
96%
last
24d ago
Digital Health
LinkedIn
Medium volume
98%
last
10d ago
Women Empowerment
LinkedIn
Medium volume
96%
last
16d ago
Follow-Up
LinkedIn
Low volume
98%
last
26d ago
Public Health
LinkedIn
Low volume
98%
last
10d ago
Patient Data
LinkedIn
Low volume
96%
last
26d ago
Patient Care
LinkedIn
Low volume
98%
last
18d ago
Medical Director
LinkedIn
Low volume
83%
last
12d ago
Financial Services
LinkedIn
Low volume
98%
last
24d ago
Scale AI
LinkedIn
Low volume
98%
last
27d ago
Primary Care
LinkedIn
Low volume
98%
last
18d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Oviva

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others7 active
Executiveresearching Artificial Intelligence
in
Senior ICresearching Women Empowerment
in
Directorresearching Mental Health
in
researching Scale AI
in
researching Health Care
in
researching Medical Director
in
Executiveresearching Digital Health
in
Engineering1 active
researching Artificial Intelligence
in
Marketing1 active
Senior ICresearching Weight Management
in

Primary products / business lines

LinkedIn company profile

We are creating a healthier future for people living with weight-related conditions by offering highly accessible & effective technology-enabled therapy. Oviva works directly with statutory health insurers, doctors and national healthcare systems in the UK, DE & CH and has treated over one million patients.

New capability sought

Employee posts (LinkedIn)

Weight Management

Top accounts researching Oviva

names withheld on the public page

These are companies whose own people brought up Oviva unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

151,426 companies · 839,012 people are researching Artificial Intelligence

Oviva's own team shows 4 signals on this topic. No one outside Oviva has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Mental Health13,563 cos · 51,459 people
  • Weight Management289 cos · 1,038 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Oviva.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Leadership — 1 person; Engineering — 1 person; Marketing — 1 person

What's been said

public posts mentioning Oviva

Up to 9 public excerpts naming Oviva from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

Hypertension isn't just the world's most common chronic disease. It's the leading risk factor for premature death and in Germany alone, it combines with obesity to drive over €100 billion in annual healthcare and productivity costs. At the same time, there is a real treatment gap: nearly 1 in 3 adults in Europe live with high blood pressure, and half of those diagnosed remain uncontrolled, despite available pharmacotherapy. The missing layer is structured lifestyle support, and it's the layer most healthcare systems struggle to deliver at scale. For World Hypertension Day, our mission at Oviva is to close this gap. In our new German GP survey, 3 in 4 doctors confirmed what we've seen for years: there is a (very) large need for additional lifestyle support for hypertension patients. That's exactly what we built. Oviva Direkt Bluthochdruck, the first dual-effect digital therapeutic reimbursed by Germany's statutory health system, delivered -11 mmHg systolic BP and -4% body weight after 3 months in the randomised HYPE trial. The same therapy that lowers blood pressure also addresses obesity, the most common comorbidity. Real savings for payers. Real productivity gains for the economy.

May 2026
LinkedIn

More than 20 million Germans live with hypertension. ~7 million of them also live with obesity. And half of all diagnosed patients remain uncontrolled despite available medication. Two of the costliest chronic diseases in our healthcare system, sharing the same patients, yet still treated in silos. As we mark World Hypertension Day, our mission at Oviva is clear: integrating structured lifestyle intervention into the standard hypertension pathway. In our new survey of 400 German practising physicians, 3 in 4 confirmed a (very) large need for exactly this kind of support. We have the evidence. With Oviva Direkt Bluthochdruck, Germany's first dual-effect Digital Therapeutic (DiGA), reimbursed by all statutory health insurers - the randomised HYPE trial showed -11 mmHg systolic BP and -4.14% body weight after 3 months. One therapy, two of Germany's biggest cost drivers addressed. Let's make this the standard, not the exception.

May 2026
LinkedIn

Half of all patients diagnosed with high blood pressure are still not at target, even with medication. For World Hypertension Day, that gap is what drives our mission at Oviva . Behind every uncontrolled reading is a person at higher risk of stroke, heart attack, and kidney disease and a system carrying the cost of preventable complications. Hypertension is the leading risk factor for premature death globally, yet structured lifestyle support is still missing from most care pathways. The doctors agree. In our new German GP survey, 3 in 4 confirmed a (very) large need for additional lifestyle support for their hypertension patients. This is where digital therapy changes the picture. In Germany, we've launched Oviva Direkt Bluthochdruck earlier this year, tthe first dual-effect Digital Therapeutic, validated in the randomised HYPE trial: -11 mmHg systolic BP & -4.14% body weight after 3 months. The same model can scale across Europe. High-quality, integrated care shouldn't be a luxury. It must become the standard for everyone.

May 2026
LinkedIn

💫 What a week. At the European Congress on Obesity in Istanbul, I presented our team's findings from 1,270 patients on the Oviva digital UK Tier-3 programme: fewer sick days, reduced healthcare resource use, real outcomes beyond the scale. The findings ran in seven major UK national outlets, including The Times (front page), The Guardian and The Telegraph, and were discussed on today’s Good Morning Britain. 📈 What it shows is something we've been arguing for a long time: effective obesity care doesn't just help individuals. It eases pressure on overstretched health systems and on the economy. That case used to be a hard sell. The data is doing the talking now. 🤝 Huge thanks to Dagmara Wozniak, PhD, MBA, Dr. Felix Schirmann and Yannick Schindler for the work behind this, and to the wider Oviva team in Istanbul this week. Full Times article in the comments ⤵️

May 2026
LinkedInEuropean Tech Startups

Back to Oviva’s Swiss roots 🇨🇭 Today I had the pleasure of joining the business lunch of the Swiss ambassador Livia Leu here in Berlin together with other startup and scale up companies. Germany remains the 🥇market for Swiss companies to expand to. This was also the case for Oviva several years ago. From the conversations over lunch I took away: * AI remains the hot topics and I feel we are doing well at Oviva of integrating it (newly founded companies that go AI-first are big source of inspiration for us) * Berlin is still a great place for growing companies in Europe and Germany. Despite some voices in the room debating the heydays are over (as having growing up as a teenager in Berlin in the 90s I have a different perspective) * Germans (and maybe Swiss people as well?) always like to complain and rarely call out the good things the government or regulators have done for them. A bit more balanced approach would do well. Thank you Die Botschaft der Schweiz in Deutschland for the invitation. I am looking forward to the next time.

May 2026

About this data. Oviva (oviva.com). Department attribution is 26.67%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries